Dr. Markham is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
705 Riley Hospital Dr
# RI1134
Indianapolis, IN 46202Phone+1 317-944-8906Fax+1 317-944-9330
Education & Training
- Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Cardiology, 2001 - 2004
- University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine/Pediatrics, 1996 - 2000
- East Tennessee State University James H. Quillen College of MedicineClass of 1996
Clinical Trials
- Eisenmenger Quality Enhancement Research Initiative Start of enrollment: 2012 Jul 01
- Adult Congenital Heart Disease Registry (QuERI) Start of enrollment: 2011 Dec 01
- Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM Start of enrollment: 2014 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 154 citationsManagement of Cardiac Involvement Associated With Neuromuscular Diseases: A Scientific Statement From the American Heart AssociationBrian Feingold, William T. Mahle, Scott R. Auerbach, Paula Clemens, Andrea A. Domenighetti
Circulation. 2017-09-26 - 322 citationsAtenolol versus Losartan in Children and Young Adults with Marfan's SyndromeRonald V. Lacro, Harry C. Dietz, Lynn A. Sleeper, Anji T. Yetman, Timothy J. Bradley
The New England Journal of Medicine. 2014-11-26 - 1 citationsMyocardial strain imaging in Duchenne muscular dystrophy.Conner C Earl, Jonathan H Soslow, Larry W Markham, Craig J Goergen
Frontiers in Cardiovascular Medicine. 2022-01-01
Journal Articles
- 2017 Riley Heart Center Symposium on Cardiac Development: Development and Repair of the Ventricular WallLarry Markham, MD, Pediatric Cardiology
Press Mentions
- Riley Nurse Using Her Journey with Congenital Heart Defects to Relate to FamiliesFebruary 19th, 2021
- FDA Awards $1M to Phase 2 Study of Ifetroban in Treating Heart Disease Linked to Duchenne MDOctober 2nd, 2019
- A Protein Could Be Key to Preserving Heart Function in DMD in ChildrenAugust 1st, 2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: